Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to All Reviews
Investigation Report
MEDvidi Tirzepatide Review
MedVidi, MEDvidi, medvidi.com
Also spelled as MedVidi, MEDvidi, medvidi.com — Same brand, same great service!
Our investigation of Compounded Tirzepatide from MEDvidi
Caution Advised
Multiple red flags identified
Caution Advised
$195 introductory consultation, $249 intro+follow-up package, $159 per follow-up. Insurance not accepted; brand-name medication cost separate
100+
Hours Researched
7
Verified Pros
7
Issues Found
6.6
Final Score
These are Med Consumer Watch products, not products from MEDvidi, the brand being reviewed on this page.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Investigation Overview
MEDvidi comes from mental health telehealth, and it shows in the assessment. Our research (August 8, 2026) found the most comprehensive intake in our set paired with a cost structure that will not suit most people.
The Assessment Is the Best Part
MEDvidi's weight-loss evaluation covers:- A weight-loss questionnaire
- Medical history review
- Physical health evaluation
- BMI measurement
- Diet and activity analysis
- Mental health screening
Brand-Name Medications
MEDvidi lists Ozempic, Wegovy and Rybelsus (semaglutide), Mounjaro and Zepbound (tirzepatide), plus Saxenda and Trulicity. These are FDA-approved products. The page does not specify whether compounded alternatives are also offered.The Cost Problem
Here is where it becomes difficult:- Introductory consultation: $195
- Introductory + follow-up package: $249 (stated to save $105)
- Follow-up consultation: $159
- "Currently, MEDvidi doesn't accept insurance"
Who That Leaves
The clinical quality is real and the price is real. This makes sense for someone who specifically needs the mental health dimension of the assessment — a complicated relationship with food, a history that warrants screening, or existing psychiatric care that interacts with weight management — and who is prepared to pay cash for both the consultation and a brand-name drug. For anyone whose primary constraint is cost, it does not. States served are not specified, and a refund policy link exists without accessible terms.Our Investigation Summary
Our research (August 8, 2026) found MEDvidi running the most comprehensive weight-loss assessment in our set — a weight-loss questionnaire, medical history review, physical health evaluation, BMI measurement, diet and activity analysis, and mental health screening — conducted by video with licensed providers. The mental health component is genuinely valuable given the overlap between obesity and disordered eating, and reflects MEDvidi's origins in mental health telehealth. It lists brand-name GLP-1s: Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda and Trulicity, without specifying whether compounded alternatives exist. The cost structure is the problem: an introductory consultation at $195, follow-ups at $159, an intro-plus-follow-up package at $249, no membership fees, and explicitly "MEDvidi doesn't accept insurance." With brand-name medication running $650–$1,599 cash-pay on top, this is the most expensive route in our comparison — Doctronic charges $39 per visit and accepts insurance. States served are not specified and refund terms are not published. Best for patients who specifically need the mental health dimension of the assessment and can pay cash for both consultation and brand-name medication.
How MEDvidi Works
1
Book an introductory consultation at $195, or the intro-plus-follow-up package at $249
2
Complete a comprehensive assessment: weight-loss questionnaire, medical history, physical health evaluation, BMI, diet and activity analysis, and mental health screening
3
Meet a licensed provider by video
4
If appropriate, receive a prescription for a brand-name GLP-1 — Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda or Trulicity
5
Follow-up consultations are $159 each
6
Budget for medication separately — MEDvidi does not accept insurance, so brand-name cash prices apply
7
Confirm your state is served, as this is not published
What We Found
What's Good
- The most comprehensive assessment in our comparison — medical history, physical health evaluation, BMI, diet and activity analysis and mental health screening
- Mental health screening is genuinely valuable given the overlap between obesity and disordered eating
- Video consultations with licensed providers rather than asynchronous form review
- Brand-name FDA-approved GLP-1s: Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda and Trulicity
- No membership fees and no hidden fees stated
- Package pricing available at $249 for introductory plus follow-up, stated to save $105
- Strong fit for patients with psychiatric history or a complicated relationship with food
Watch Out For
- Does not accept insurance, so full brand-name cash prices of roughly $650–$1,599/month apply on top
- $195 introductory consultation is far above competitors charging $34–$49
- $159 per follow-up consultation makes ongoing care expensive
- The most expensive overall route in our comparison set
- Medication pricing is not published
- Does not specify whether compounded alternatives are offered
- States served and refund terms are not published
Pricing Breakdown
Starting Price
$195 introductory consultation; $249 for the introductory plus follow-up package
Medication Cost
Not included and not published. Brand-name GLP-1s run approximately $650–$1,599 per month cash-pay, since insurance is not accepted
Subscription Fees
None — no membership, and the company states no hidden fees. Follow-up consultations are $159 each
Hidden Fees
None advertised, but note that insurance is explicitly not accepted, so the full brand-name cash price applies on top of consultation fees. Refund terms are not published
Safety & Medical Oversight
MEDvidi's assessment is the most thorough in our comparison set: weight-loss questionnaire, medical history review, physical health evaluation, BMI, diet and activity analysis, and mental health screening, delivered by video consultation with licensed providers. The mental health screening deserves particular note — obesity and disordered eating overlap substantially, an eating disorder history is a genuine reason for caution with appetite-suppressing medication, and a questionnaire-based competitor will not detect it. MEDvidi lists FDA-approved brand-name GLP-1s (Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Trulicity), which carry full FDA labelling and the trial evidence behind them; the page does not state whether compounded alternatives are also offered, so ask. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and require caution with a history of pancreatitis, gallbladder disease, gastroparesis or diabetic retinopathy. If you take psychiatric medication, the video consultation is the right place to review interactions and the effect of altered gastric emptying on absorption.
Customer Support
Care is delivered through scheduled video consultations with licensed providers rather than messaging, with follow-ups priced individually at $159. That is a genuine clinical relationship, and the assessment depth exceeds anything else in our set. The countervailing factor is purely economic: at $195 initial and $159 per follow-up with no insurance accepted, ongoing care costs considerably more than competitors charging $34–$49 per visit. States served and refund terms are not published. We found no substantial independent review record specific to the weight-loss service.
Key Features
Comprehensive Assessment Incl. Mental Health Screening
Video Consultations With Licensed Providers
Brand-Name Ozempic, Wegovy & Rybelsus
Mounjaro, Zepbound, Saxenda & Trulicity
$195 Introductory Consultation
$249 Intro + Follow-Up Package
$159 Follow-Up Consultations
No Membership Fees
Best For
Patients who specifically need the mental health dimension of a weight-loss assessment — psychiatric history or a complicated relationship with food — and can pay cash for consultation and brand-name medication
Customer Reviews & Complaints
We looked for independent customer feedback on MEDvidi's weight-loss service as of August 8, 2026 and found little substantial third-party record specific to GLP-1 treatment.
What we verified directly from the company's own pages: consultation pricing at $195 introductory, $249 for the intro-plus-follow-up package and $159 per follow-up; the explicit statement that insurance is not accepted; the absence of membership fees; the brand-name GLP-1 list; and the comprehensive assessment including mental health screening delivered by video with licensed providers.
The tension in this offering is not a complaint pattern, it is arithmetic. The clinical quality is the best in our set and the cost is the highest in our set, and those two facts are related — a thorough video assessment by a licensed provider genuinely costs more to deliver than an asynchronous questionnaire review. The question is whether you need what you are paying for.
What we could not verify: states served, refund terms, medication pricing, and whether compounded alternatives are offered.
Is MEDvidi Legit?
"Is MEDvidi legit?" Our assessment as of August 8, 2026.
Official Verification: MEDvidi operates a functioning telehealth service with licensed providers conducting video consultations and a structured, documented assessment process. We found no indication of misrepresentation, and its consultation pricing is published clearly.
The clinical depth is real and worth naming. Including mental health screening in a weight-loss assessment is not standard in this category and it addresses a genuine risk — appetite-suppressing medication and a history of disordered eating is a combination that warrants professional attention, and it is precisely what a three-minute intake form will miss.
The economics are the constraint. No insurance acceptance plus brand-name-only medication plus $195/$159 consultation fees produces the highest total cost of any route we have priced. That is not a criticism of honesty — every figure is disclosed — but it narrows sharply who this is right for.
Red Flags Check:
- ✓ Video consultations with licensed providers
- ✓ Most comprehensive assessment in our set, including mental health screening
- ✓ Brand-name FDA-approved medications
- ✓ Consultation pricing published clearly
- ✓ No membership or hidden fees
- ⚠ Insurance explicitly not accepted
- ⚠ $195 initial and $159 follow-up consultations, far above competitors
- ⚠ Medication pricing not published
- ⚠ States served and refund terms not published
The Bottom Line: The best clinical assessment we have found and the most expensive way to obtain a GLP-1. If you have a psychiatric history or a complicated relationship with food, the mental health screening may be worth exactly what it costs. If cost is your binding constraint, Doctronic at $39 a visit with insurance accepted, or Sesame at $34, do the prescribing part for a fraction of the price. As always, consult your personal physician before starting any new medication program.
Our Verdict: Caution Advised
MEDvidi has a 6.6/10 site score. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit MEDvidiMEDvidi
Caution Advised
6.6/10
$195 introductory consultation, $249 intro+follow-up package, $159 per follow-up. Insurance not accepted; brand-name medication cost separate
Prescription treatment requires clinician review
Investigation Summary
Overall Rank#129 of 226
Rating6.6/10
StatusCaution Advised
Pricing$195 introductory consultation, $249 intro+follow-up package, $159 per follow-up. Insurance not accepted; brand-name medication cost separate
Share Your Experience
Help others by sharing your experience with MEDvidi
Want to compare options?
View All 226 ProvidersUser Reviews
Rating Summary
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
226 Providers Reviewed
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Promotional placement: CoreAge Rx is featured #1 and SuperHealthy Rx #2. Placements and site scores are not independent clinical ratings or patient review averages. We may earn compensation from referral links. How our rankings work.
#1 RecommendedExcellent
#2 RecommendedExcellent
#3 RecommendedGreat
Mochi Health
8.8
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
More Provider Reviews
CoreAge Rx
9.9
SuperHealthy Rx
9.7
Mochi Health
8.8
Remedy Meds
8.3
Caution Advised
Ready to Get Started with MEDvidi?
Review our findings above and make an informed decision about MEDvidi.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.